These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 11574460

  • 1. Insulin therapy does not itself induce weight gain in patients with type 2 diabetes.
    Larger E, Rufat P, Dubois-Laforgue D, Ledoux S.
    Diabetes Care; 2001 Oct; 24(10):1849-50. PubMed ID: 11574460
    [No Abstract] [Full Text] [Related]

  • 2. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C.
    Diabetes Educ; 2006 Oct; 32(6):910-7. PubMed ID: 17102158
    [Abstract] [Full Text] [Related]

  • 3. At last, a weight neutral insulin?
    Fritsche A, Häring H.
    Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S41-6. PubMed ID: 15306837
    [Abstract] [Full Text] [Related]

  • 4. Does insulin detemir have a role in reducing risk of insulin-associated weight gain?
    Hermansen K, Davies M.
    Diabetes Obes Metab; 2007 May; 9(3):209-17. PubMed ID: 17391147
    [Abstract] [Full Text] [Related]

  • 5. Early use of insulin in type 2 diabetes.
    Eldor R, Stern E, Milicevic Z, Raz I.
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S30-5. PubMed ID: 15955372
    [Abstract] [Full Text] [Related]

  • 6. Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done?
    Brown A, Guess N, Dornhorst A, Taheri S, Frost G.
    Diabetes Obes Metab; 2017 Dec; 19(12):1655-1668. PubMed ID: 28509408
    [Abstract] [Full Text] [Related]

  • 7. Durable efficacy of liraglutide in patients with type 2 diabetes and pronounced insulin-associated weight gain: 52-week results from the Effect of Liraglutide on insulin-associated wEight GAiN in patients with Type 2 diabetes' (ELEGANT) randomized controlled trial.
    de Wit HM, Vervoort GM, Jansen HJ, de Galan BE, Tack CJ.
    J Intern Med; 2016 Mar; 279(3):283-92. PubMed ID: 26553486
    [Abstract] [Full Text] [Related]

  • 8. [Mechanisms for weight gain during blood glucose normalization].
    Laville M, Andreelli F.
    Diabetes Metab; 2000 Jun; 26 Suppl 3():42-5. PubMed ID: 10945152
    [Abstract] [Full Text] [Related]

  • 9. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes: response to Martin et al.
    Mark DA.
    Diabetes Care; 2006 Dec; 29(12):2764; author reply 2764-5. PubMed ID: 17130232
    [No Abstract] [Full Text] [Related]

  • 10. Is a failure to recognize an increase in food intake a key to understanding insulin-induced weight gain?
    Ryan M, Livingstone MB, Ducluzeau PH, Sallé A, Genaitay M, Ritz P.
    Diabetes Care; 2008 Mar; 31(3):448-50. PubMed ID: 18086874
    [Abstract] [Full Text] [Related]

  • 11. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
    Westphal SA, Palumbo PJ.
    Arch Intern Med; 2008 Mar; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
    [No Abstract] [Full Text] [Related]

  • 12. Insulin therapy and weight change in Native-American NIDDM patients.
    Hickey ME, Hall TR.
    Diabetes Care; 1993 Jan; 16(1):364-8. PubMed ID: 8422812
    [Abstract] [Full Text] [Related]

  • 13. Weight gain during insulin therapy in patients with type 2 diabetes mellitus.
    Heller S.
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S23-7. PubMed ID: 15315867
    [Abstract] [Full Text] [Related]

  • 14. Combination therapies with insulin in type 2 diabetes.
    Yki-Järvinen H.
    Diabetes Care; 2001 Apr; 24(4):758-67. PubMed ID: 11315844
    [No Abstract] [Full Text] [Related]

  • 15. Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index.
    Raslová K, Tamer SC, Clauson P, Karl D.
    Clin Drug Investig; 2007 Apr; 27(4):279-85. PubMed ID: 17358100
    [Abstract] [Full Text] [Related]

  • 16. [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].
    Hermann LS, Melander A.
    Lakartidningen; 1999 Dec 15; 96(50):5616-9. PubMed ID: 10643226
    [Abstract] [Full Text] [Related]

  • 17. Biphasic insulin aspart 30 as insulin initiation or replacement therapy: the China cohort of the IMPROVE study.
    Yang W, Gao Y, Liu G, Chen L, Fu Z, Zou D, Feng P, Zhao Z.
    Curr Med Res Opin; 2010 Jan 15; 26(1):101-7. PubMed ID: 19916705
    [Abstract] [Full Text] [Related]

  • 18. The gain game.
    Gebel E.
    Diabetes Forecast; 2012 Oct 15; 65(10):28-9. PubMed ID: 23038947
    [No Abstract] [Full Text] [Related]

  • 19. [Insulin and weight gain: myth or reality?].
    Larger E, Rufat P, Dubois-Laforgue D, Ledoux S.
    Diabetes Metab; 2001 Nov 15; 27(5 Pt 3):S23-7. PubMed ID: 11910976
    [Abstract] [Full Text] [Related]

  • 20. Weight gain in type 2 diabetes mellitus--not all uphill.
    Cohen O, Norymberg C, Neumann E, Dekel H.
    Diabetes Res Clin Pract; 2008 Jan 15; 79(1):128-32. PubMed ID: 17720273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.